NEJM 2026, Phase III ATOMIC Trial. Immune checkpoint inhibitors have done it again🤤. On October 8, 2026, the U.S. FDA ...
The safety profile of TFOX was consistent with data reported in previous studies, and no new safety signals were identified. A modified chemotherapy regimen consisting of docetaxel, folinic acid ...
Standard adjuvant chemotherapy for stage III colon cancer consists of a fluoropyrimidine-plus-oxaliplatin regimen. Whether the addition of atezolizumab (an anti–programmed death ligand 1 agent) to a ...
The 10th FOLFOX treatment has begun, and the oxaliplatin administration is finished. Up until now, I haven't had any major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results